Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial

Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial

Community-Acquired Pneumonia (CAP) is a major public health problem. In Brazil it has been estimated that 2,000,000 people are affected by CAP every year. Of those, 780,000 are admitted to hospital, and 30,000 have death as the outcome. This is an open-label, non-comparative study with the purpose o...

Full description

Bibliographic Details
Main Authors: Fernando G. Rubio, Clóvis A. Cunha, Fernando L.C. Lundgren, Maria P.J.S. Lima, Paulo J.Z. Teixeira, Julio C.A. Oliveira, Valdir Golin, Waldo L.L.D. Mattos, Herbert K. Mählmann, Edson D. Moreira, Jose R. Jardim, Rodney L.F. Silva, Patricia H.B. Silva
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Community acquired infections
pneumonia
anti-bacterial agents
macrolide ketolides
azithromycin
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000300008&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000300008&lng=en&tlng=en

Similar Items